Table 1. Patient Characteristics.

Age
median (range), years	74 (48–93)
Gender
female	37 (78.7%)
male	10 (21.3%)
Primary tumor expansion (pT)
pT1	6 (12.8%)
pT2	17 (36.2%)
pT3	20 (42.6%)
pT4	3 (6.4%)
Lymph node involvement (pN)
pN0	37 (78.7%)
pN1	10 (21.3%)
Grade of Dedifferentiation (G)
G2	17 (36.2%)
G3	28 (59.6%)
Overall Survival
median (range), months	13 (0–69)